[HTML][HTML] Endocrine risk factors for COVID-19: Endogenous and exogenous glucocorticoid excess

F Vogel, M Reincke - Reviews in Endocrine and Metabolic Disorders, 2022 - Springer
Patients with endogenous or exogenous glucocorticoid (GC) excess exhibit a range of side
effects, including an increased risk of infections. Via both mechanism, immune impairments …

Endocrine risk factors for COVID-19: Endogenous and exogenous glucocorticoid excess

F Vogel, M Reincke - Reviews in Endocrine & Metabolic …, 2022 - search.proquest.com
Patients with endogenous or exogenous glucocorticoid (GC) excess exhibit a range of side
effects, including an increased risk of infections. Via both mechanism, immune impairments …

Endocrine risk factors for COVID-19: Endogenous and exogenous glucocorticoid excess

F Vogel, M Reincke - Reviews in endocrine & metabolic …, 2021 - epub.ub.uni-muenchen.de
Patients with endogenous or exogenous glucocorticoid (GC) excess exhibit a range of side
effects, including an increased risk of infections. Via both mechanism, immune impairments …

Endocrine risk factors for COVID-19: Endogenous and exogenous glucocorticoid excess.

F Vogel, M Reincke - Reviews in Endocrine & Metabolic Disorders, 2021 - europepmc.org
Patients with endogenous or exogenous glucocorticoid (GC) excess exhibit a range of side
effects, including an increased risk of infections. Via both mechanism, immune impairments …

Endocrine risk factors for COVID-19: Endogenous and exogenous glucocorticoid excess

F Vogel, M Reincke - Reviews in endocrine & metabolic …, 2022 - pubmed.ncbi.nlm.nih.gov
Patients with endogenous or exogenous glucocorticoid (GC) excess exhibit a range of side
effects, including an increased risk of infections. Via both mechanism, immune impairments …

[HTML][HTML] Endocrine risk factors for COVID-19: Endogenous and exogenous glucocorticoid excess

F Vogel, M Reincke - Reviews in Endocrine & Metabolic Disorders, 2022 - ncbi.nlm.nih.gov
Patients with endogenous or exogenous glucocorticoid (GC) excess exhibit a range of side
effects, including an increased risk of infections. Via both mechanism, immune impairments …

Endocrine risk factors for COVID-19: Endogenous and exogenous glucocorticoid excess

F Vogel, M Reincke - Reviews in endocrine & metabolic …, 2021 - epub.ub.uni-muenchen.de
Patients with endogenous or exogenous glucocorticoid (GC) excess exhibit a range of side
effects, including an increased risk of infections. Via both mechanism, immune impairments …